- Eli Lilly results blow past estimates on strong Zepbound launch, surging Mounjaro revenue CNBC
- Lilly expects strong 2024 profit on rising demand for weight-loss drug Yahoo Finance
- Lilly Reports Strong Fourth-Quarter 2023 Financial Results and Provides 2024 Guidance | Eli Lilly and Company Investors | Eli Lilly and Company
- Live news: Eli Lilly says diabetes and obesity drugs will boost sales by 20% this year Financial Times
- Eli Lilly Posts Earnings Beat. The Stock Is Rising. Barron’s